1,343 results on '"Wedzicha Jadwiga A"'
Search Results
2. Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease
3. Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study
4. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.
5. Lung-function trajectories: relevance and implementation in clinical practice
6. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
7. Chronic obstructive pulmonary disease: management of chronic disease
8. The Effect of Inhaled Corticosteroids on Pneumonia Risk in Patients With COPD-Bronchiectasis Overlap: A UK Population-Based Case-Control Study
9. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
10. Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
11. Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
12. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
13. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
14. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
15. Early childhood lower respiratory tract infection and premature adult death from respiratory disease in Great Britain: a national birth cohort study
16. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
17. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
18. Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry
19. Lung-function trajectories: relevance and implementation in clinical practice
20. Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
21. Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies
22. Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
23. Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease.
24. Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement
25. Early Diagnosis and Treatment of COPD: The Costs and Benefits of Case-Finding
26. Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial
27. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
28. Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials
29. Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.
30. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050
31. Lower respiratory tract infections in early childhood – Authors' reply
32. Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials
33. A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
34. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
35. Recognising exacerbations in Early COPD
36. Association of a polygenic risk score for chronic obstructive pulmonary disease with lung function across the lifespan
37. Mucus, microbiomes, and lung function decline in COPD
38. Coronary artery disease, COPD exacerbation and inflammation
39. RSV as a Cause of Exacerbations of COPD
40. Blood eosinophil counts in younger smokers from the Early COPD Development Partnership
41. Fibrinogen as a biomarker of cardiovascular risk in COPD
42. The economic and health burden of COPD in the Middle East: forecasting through 2050
43. COPD Assessment Test (CAT) Score according to the presence/absence of accelerated lung function decline in young adult smokers with normal FEV1
44. Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
45. A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
46. Causes of Death in Smokers: Implications for Chronic Obstructive Pulmonary Disease Management across Disease Severity
47. Professor Gavin Donaldson. 1961–2023
48. Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease
49. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial
50. Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.